NCT05218616 - The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 21, 2022

Primary Completion Date

March 3, 2022

Study Completion Date

May 3, 2022

Conditions

Bioequivalence

Interventions

DRUG

Aviga, capsules 50 mg / Sutent®, capsules 50 mg

Aviga is manufactured by JLLC NATIVITA, Republic of Belarus. Each capsule contains 50 mg of Sunitinib / Sutent® is manufactured by Pfizer Italia S.R.L., Italia. Each capsule contains 50 mg of Sunitinib.

DRUG

Sutent®, capsules 50 mg / Aviga, capsules 50 mg

Sutent® is manufactured by Pfizer Italia S.R.L., Italia. Each capsule contains 50 mg of Sunitinib / Aviga is manufactured by JLLC NATIVITA, Republic of Belarus. Each capsule contains 50 mg of Sunitinib

Trial Locations (1)

223040

National Anti-Doping Laboratory, Lyasny